Biocampus

  • Schrift vergrößern
  • Standard-Schriftgröße
  • Schriftgröße verkleinern

Nexigen GmbH

E-Mail Drucken PDF

 

Nexigen GmbH is a biopharmaceutical company with a staff of 24 people. The aim of the company is the development of novel drugs, which utilize so far inaccessible disease mechanisms. Nexigen's technology platform enables the development of drugs with novel potentially superior properties and associated important USPs. The company focuses on the development of therapeutics in oncological indications.


Nexigen's technology platform includes screening systems in living cells. These systems allow for the identification of drug precursors under natural conditions in a unique way and feature a high hit rate and the identification of relevant molecules. This results in a significant saving of time and effort during further development. Additional components of the technology platform allow for the efficient optimization of the identified drug precursors.


Currently Nexigen GmbH cooperates with various biotech companies and successfully completed projects with leading pharmaceutical companies.

 

 

 

Nexigen GmbHalt

Geschäftsführer

Jan Jennes

Nattermannallee 1
50829 Köln

Tel.: +49 221 33 777 2-00
Fax: +49 221 33 777 2-29
E-mail: jennes@nexigen.de